Xcout IntelSign inSubscribe

GUIDED THERAPEUTICS INC competitors & alternatives

GTHPBiotechPeachtree Corners, United States

The 12 closest competitors and alternatives to GUIDED THERAPEUTICS INC among biotech companies — ranked by similarity to what GUIDED THERAPEUTICS INC actually does, not by market-cap band.

$17.4MMarket cap
4Employees
12Competitors listed

Subscribe to see GUIDED THERAPEUTICS INC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About GUIDED THERAPEUTICS INC

Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, non-invasive manner, directly at the point of care. LuViva operates by scanning the cervix with light and subsequently analyzing both the reflected and fluorescent light emitted. Established in 1992 and headquartered in Norcross, Georgia, the company was formerly known as SpectRx, Inc. until its rebranding to Guided Therapeutics, Inc. in February 2008.

GUIDED THERAPEUTICS INC at a glance

GUIDED THERAPEUTICS INC is a biotech company headquartered in Peachtree Corners, United States. It is publicly listed (GTHP) with a market capitalisation of $17.4M. Xcout tracks 5 named people at GUIDED THERAPEUTICS INC, including Mark L. Faupel (Chief Executive Officer, President, Chief Operating Officer, Acting Chief Financial Officer, Secretary & Director).

GUIDED THERAPEUTICS INC leadership

  • Mark L. FaupelChief Executive Officer, President, Chief Operating Officer, Acting Chief Financial Officer, Secretary & Director
  • Alan GrujicDirector
  • John E ImhoffDirector
  • Michael C JamesDirector
  • Richard P. BlumbergDirector

GUIDED THERAPEUTICS INC funding rounds before its IPO

Every round on record:

DateRoundAmountInvestors
Series A$9.1M—

Financing after the IPO — public offerings and SEC Form D private placements — is not listed as a funding round.

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 GUIDED THERAPEUTICS INC competitors

Ranked by semantic similarity — how close each company is to GUIDED THERAPEUTICS INC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

CELLBXHEALTH PLCCLBX · BiotechGuildford, United Kingdom
64% matchPublic

Similar biotech company

CelLBxHealth plc is a medical diagnostics firm specializing in the creation of cancer detection solutions, with operations spanning the United Kingdom, broader Europe, North America, and other global markets. A flagship offering is the Parsortix PC1 system, a medical device engineered to isolate and collect whole circulating tumor cells (CTCs) from the blood of patients with metastatic breast cancer, preparing them for further user-validated analysis. The company also provides the Parsortix PR1 system for general CTC capture and collection from blood samples. Beyond its core systems, CelLBxHealth offers the Portrait+ CTC Staining kit, a laboratory solution designed for the precise identification, characterization, and quantification of both epithelial and mesenchymal circulating tumor cells, boasting strong analytical sensitivity and specificity. Another key product is the CellKeep Slide, which facilitates CTC harvesting. The company extends its expertise through various laboratory services, including advanced CTC enrichment and liquid biopsy analysis. Its assay portfolio comprises Portrait Flex, an immunofluorescence assay for detecting epithelial, mesenchymal, and epithelial-to-mesenchymal transition states, as well as assessing DNA damage response. Additionally, CelLBxHealth provides Portrait PD-L1 for CTC evaluation and develops customized CTC assays. Strategic collaborations underpin some of its development efforts; it has partnered with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. involves utilizing a pan-cancer next-generation sequencing (NGS) panel. Originally established in 1994 as ANGLE plc, the company rebranded to CelLBxHealth plc in October 2025 and operates from its base in Guildford, UK.

Market cap$20.4M
Employees119
CELLBXHEALTH PLC competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of GUIDED THERAPEUTICS INC and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for GUIDED THERAPEUTICS INCand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →